Paclitaxel Ameliorates Lipopolysaccharide-Induced Kidney Injury by Binding Myeloid Differentiation Protein-2 to Block Toll-Like Receptor 4–Mediated Nuclear Factor-κB Activation and Cytokine Production

Abstract

Recent studies suggest that paclitaxel, an anticancer agent, may modulate the injury and inflammatory responses in normal tissues. However, the underlying mechanism is not fully understood. Here we have examined the effect of paclitaxel on lipopolysaccharide (LPS)-induced acute kidney injury (AKI) in mice and further studied the mechanism. At relatively low doses, paclitaxel protected against LPS-induced AKI and improved animal survival. The beneficial effects of paclitaxel were accompanied by the downregulation of tumor necrosis factor-a, interleukin-1, and interleukin-6 production. In cultured renal tubular HK-2 cells, paclitaxel decreased the DNA-binding activity of nuclear factor-kB (NF-kB) during LPS treatment, inhibited the degradation of the inhibitor of kB-a, and blocked the expression and activation of NF-kB p65. At the upstream level, paclitaxel reduced LPS-induced association of myeloid differentiation protein-2 (MD-2) with Toll-like receptor 4 (TLR4). In an in vitro assay, paclitaxel was shown to directly bind recombinant MD-2. The inhibitory effect of paclitaxel on NF-kB activation and cytokine expression disappeared in MD-2 knockdown cells, indicating that paclitaxel acts through MD-2. Collectively, these results suggest that paclitaxel may bind MD-2 to block MD-2/ TLR4 association during LPS treatment, resulting in the suppression of NF-kB activation and inhibition of proinflammatory cytokine production.

Establishment of HK-2 Cells as a Relevant Model to Study Tenofovir-Induced Cytotoxicity

“…These changes in TNFα expression and secretion can modulate various parts of the cellular antioxidant system and directly increase the production of mitochondrial reactive oxygen species through damage to the electron transport chain [30]. In experiments involving exposing HK-2 cells to toxicants and/or ischemic injury, TNFα levels rose along with many other markers of toxicity, including increases in oxidative stress via dysfunction of cellular antioxidant systems, activation of an inflammatory response and associated proteins, and induction of programmed cell death [31,32,33]. We examined TNFα as a potential indicator of oxidative stress.…”

p53 activates miR-192-5p to mediate vancomycin induced AKI

“…BUN and serum creatinine were measured with commercial kits from Stanbio Laboratory112243. For the histological analysis, kidney tissues fixed with 4% buffered paraformaldehyde were embedded in paraffin, and 4 μm thick sections were prepared.…”

Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update

“…On the contrary, recent data show that 16 can block NF-κB activation and cytokines expression by binding to human MD-2 as an antagonist, thus ameliorating TLR4-dependent pathologies such as LPS-induced kidney injury. 57 The species-specific action of 16 has been explained in terms of different binding to MD-2. 58 16 binding to murine MD-2 causes a shift of 123–130 loop , including Phe126, outward the protein surface thus creating a binding interface for TLR4 dimerization and formation of the activated TLR4.MD-2 dimer.…”